Novel Methods To Assess The Effectiveness Of Chemotherapy In Aml Patients: Mrd

Novel methods to assess the effectiveness of chemotherapy in AML patients: MRD

VJHemOnc – Video Journal of Hematology & HemOnc

Novel techniques being used for MRD assessment in AML & the importance of considering oligoclonality

VJHemOnc – Video Journal of Hematology & HemOnc

Acute Myeloid Leukemia: Novel Therapies for Newly Diagnosed Patients - Part 1

Methods to evaluate MRD in AML

VJHemOnc – Video Journal of Hematology & HemOnc

Novel Therapies for Acute Myelogenous Leukemia (AML)

Leukemia Research Foundation

MRD Monitoring in Acute Myeloid Leukemia

Acute Myeloid Leukemia: Novel Therapies for Newly Diagnosed Patients - Part 2

MRD-guided therapy in patients with intermediate-risk AML compared to unguided cohort using PSM

VJHemOnc – Video Journal of Hematology & HemOnc

MRD Assessment and its Clinical Implications in AML

MRD in AML: What is it and what do I do about it?

AML: novel conditioning and maintenance strategies

VJHemOnc – Video Journal of Hematology & HemOnc

How can MRD guide treatment of AML?

VJHemOnc – Video Journal of Hematology & HemOnc

Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways

Methods to measure MRD & its role in predicting patient outcomes in AML

VJHemOnc – Video Journal of Hematology & HemOnc

Novel treatment combinations in AML: what’s to come?

VJHemOnc – Video Journal of Hematology & HemOnc

Novel Therapies in Myeloid Neoplasms

LurieCancerCenter

MRD negativity assessed by flow cytometry associated with improved outcomes in NPM1-mutated AML

VJHemOnc – Video Journal of Hematology & HemOnc

Maintenance and Continuous Treatment in Acute Myeloid Leukemia

Beat AML: A New Clinical Trial for Acute Myeloid Leukemia Patients

Leukemia & Lymphoma Society

Significance of Minimal Residual Disease in Acute Myeloid Leukemia